Comments
Loading...

BioCryst Pharma

BCRXNASDAQ
Logo brought to you by Benzinga Data
$7.57
0.182.44%
At close: -
$7.63
0.060.79%
After Hours: Dec 20, 6:00 PM EDT

BioCryst Pharma (NASDAQ:BCRX) Stock Quotes, Forecast and News Summary

BioCryst Pharma Stock (NASDAQ: BCRX) stock price, news, charts, stock research, profile.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
2
1
Aug
2
1
Nov
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$7.25
Close$7.57
Volume / Avg.5.07M / 2.00M
Day Range$7.25 - $7.60
52 Wk Range4.03 - 8.88
Market Cap$1.58B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
52
Short Interest
9.42%
Days to Cover11.08

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
BCRX
ARQT

FAQ

Q

How do I buy BioCryst Pharma (BCRX) stock?

A

You can purchase shares of BioCryst Pharma (NASDAQ:BCRX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are BioCryst Pharma (BCRX) competitors?

Q

What is the forecast, or price target, for BioCryst Pharma (BCRX) stock?

A

BioCryst Pharma has a consensus price target of $13.22.

Q

What is the current price for BioCryst Pharma (BCRX)?

A

The stock price for BioCryst Pharma (NASDAQ: BCRX) is $7.63 last updated December 20, 2024 at 6:00 PM EST.

Q

Does BioCryst Pharma (BCRX) pay a dividend?

A

There are no upcoming dividends for BioCryst Pharma.

Q

When is BioCryst Pharma (NASDAQ:BCRX) reporting earnings?

A

BioCryst Pharma’s Q4 earnings are confirmed for Monday, February 24, 2025.

Q

Is BioCryst Pharma (BCRX) going to split?

A

There is no upcoming split for BioCryst Pharma.

Q

What sector and industry does BioCryst Pharma (BCRX) operate in?

A

BioCryst Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch